Antifibrotic Therapy Decision-Making in Pulmonary Fibrosis
NCT07722507
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Progressive Pulmonary Fibrosis
Interventions
DRUG:
Antifibrotic therapy
Sponsor
Bristol-Myers Squibb